Executive Summary: Key Legal and Evidentiary Issues

• Interpretation of the interest clause on the balance of sale price for a pharmacy business, including whether the first interest payment is calculated on the original or adjusted balance.
• Effect of a post-closing price adjustment mechanism tied to reduced pharmacy “achalandage” (clientele) when the seller continues to operate a nearby competing pharmacy.
• Determination of whether an apparently clear contractual term can be treated as ambiguous when read in light of subsequent facts and the parties’ conduct.
• Application of Quebec Civil Code rules on contractual interpretation (arts. 1425–1427, 1432 C.c.Q.) to reconcile definitions of “solde de prix de vente” and the interest-payment clause.
• Assessment of a counterclaim seeking compensation for a party’s own time spent preparing and attending small claims proceedings, and whether such time can be recovered as damages.
• Allocation of costs where both the principal claim and the counterclaim are dismissed and neither party had clearly addressed a contractual ambiguity in advance.

Background and sale of the pharmacy

Pharmacie Ian-Philip Paul-Hus inc. had operated a community pharmacy in Varennes, Quebec, for about 20 years before deciding to sell the business. On 8 January 2024, it sold its business (fonds de commerce) to Pharmacie Bruce Noivo et Aleksandar Vulic inc. under an asset purchase agreement covering the pharmacy located at 102-303 de la Marine in Varennes. The contract provided for a balance of sale price, described as the “Solde de prix de vente,” payable on 8 January 2027. The seller’s owner, Ian-Philip Paul-Hus, continued to operate another pharmacy only a few kilometres away, and the parties anticipated that some customers would transfer their files to his new location. This anticipated shift in clientele (achalandage) was central to the pricing and adjustment mechanism in the contract.

Key contractual provisions and price adjustment mechanism

The contract defined “Solde de prix de vente” in clause 1.29 as the balance of the sale price due on the assets sold, as specified in article 4.3. The purchase price of the pharmacy’s “achalandage” (goodwill) was detailed in schedule 3.1 and was expressly subject to downward adjustment. Clause 3.2.3 stipulated that the goodwill component of the price would be reduced if the gross profits from the professional side of the pharmacy between 8 January 2024 and 7 January 2025 were less than 1,215,000$. While the formula itself was not set out in detail in the judgment, it operated so that weaker-than-expected performance—largely due to the anticipated transfer of clientele—would reduce the final balance of price. Clause 4.3 established that the balance of sale price was initially 1,000,000$, payable subject to the adjustment mechanism in clause 3.2.3, and that this balance would bear interest. The interest provision stated that the balance of sale price would bear interest at six per cent (6.0%) per year, with interest payable annually on the anniversary date of the transaction. The first interest payment was due on 8 January 2025. Clause 3.2.3 further required that the adjusted balance of sale price be calculated at the latest on 30 April 2025 and would be deemed final and binding unless the vendors objected in writing within 15 days. By 24 January 2025, the parties agreed on the adjusted balance, fixing it at 583,391.44$ after verifying the achalandage in accordance with the contract.

Emergence of the dispute over interest

The dispute arose over how to calculate the first annual interest payment due on 8 January 2025. According to Pharmacie Ian-Philip Paul-Hus inc., the first interest payment had to be calculated on the unadjusted contractual balance of 1,000,000$ as it existed at the signing of the contract. On this view, the parties already knew that six per cent of 1,000,000$ equalled 60,000$, and nothing in the interest clause expressly tied the first payment to a future adjusted balance. Pharmacie Noivo et Vulic paid only 35,004.49$ on 27 January 2025, which it calculated as six per cent interest on the agreed adjusted balance of 583,391.44$. Pharmacie Paul-Hus took the position that it was entitled to the full 60,000$ for the first year and sued in small claims for the alleged shortfall. To stay within the small claims jurisdictional limit, it reduced its claim to 15,000$, representing part of the difference between 60,000$ and 35,004.49$. In response, Pharmacie Bruce Noivo et Aleksandar Vulic inc. argued that interest was payable on the “solde de prix de vente ajusté” (adjusted balance of sale price), not the original theoretical balance. It contended that paying interest on 1,000,000$ would mean paying interest on approximately 416,608.56$ that was never actually owed once the price was adjusted for the loss of clientele, much of which was attributable to patients following Mr. Paul-Hus to his new pharmacy. The buyer argued that had it known the first year’s interest would be fixed on the unadjusted amount regardless of subsequent adjustment, it would not have accepted that clause or the initial price.

Court’s analysis on contractual interpretation

The Court of Québec, Small Claims Division, framed the central issue as whether the clause dealing with the first interest payment was clear or ambiguous. If clear, the court’s role would be to apply it as written; if ambiguous, it had to examine the parties’ common intention under the general principles of contractual interpretation from the Civil Code of Québec and case law. Drawing on authorities such as Uniprix inc. v. Gestion Gosselin et Bérubé inc. and Newad Media, the judge observed that a provision may appear clear in isolation but become ambiguous when read in light of the contract as a whole, subsequent events, and the parties’ conduct. The court noted that “Solde de prix de vente” was expressly defined in clause 1.29 by reference to clause 4.3, and that clause 4.3 in turn made clear that the balance of price was subject to adjustment. It would have been simple, the court remarked, for the parties to specify that the first interest payment would be a fixed 60,000$ irrespective of any later adjustment, or that it was to be calculated on the unadjusted balance as of 8 January 2025. The fact that they did not do so, combined with the built-in adjustment mechanism and the surrounding commercial context, created sufficient ambiguity to justify looking beyond the literal wording. The judge found that both interpretations had surface plausibility: the seller’s chronological reading—interest due on 8 January 2025 based on the then-stated 1,000,000$ balance—and the buyer’s economic reading—interest payable only on the true adjusted balance actually owed. However, when the contract was read as a whole and in light of the parties’ expectations that achalandage would likely fall and the price would likely be reduced, the court concluded that Pharmacie Noivo’s interpretation better reflected the commercial bargain. Mr. Paul-Hus had never, in economic reality, been entitled to 1,000,000$ as a balance of price; the amount was adjusted downward by more than 58%. Awarding interest as though 1,000,000$ had been payable would effectively grant him a return on capital he had not advanced and to which he ultimately had no right. It would also generate an effective interest rate of roughly 10.285% on the adjusted balance, far beyond the 6% rate explicitly stipulated, without any evidence that the parties intended such a premium. Applying the Civil Code rules on interpretation, including the requirement to seek the common intention of the parties and to interpret clauses in harmony with the rest of the contract, the court therefore adopted the buyer’s reading: interest was to be paid on the actual adjusted balance of sale price, not the original theoretical balance. On that basis, the 35,004.49$ interest payment already made fully discharged the first year’s interest obligation. The seller’s claim for additional interest was rejected.

Counterclaim for time and expenses

Pharmacie Bruce Noivo et Aleksandar Vulic inc. filed a counterclaim seeking 1,874$ from Pharmacie Ian-Philip Paul-Hus inc. for time allegedly lost in dealing with the lawsuit. It claimed payment for a full working day (8 hours) to attend court, plus two hours to prepare the case, at 150$ per hour (its and a replacement pharmacist’s rate), along with 374$ in contestation fees. The counterclaim was unsupported by documentary evidence and rested primarily on the owner’s assertion that the original claim was “irrational.” The court firmly rejected this position. It held that the mere fact a claim is dismissed does not make it irrational. More fundamentally, in the Small Claims Division, parties cannot be represented by lawyers, in part to simplify the process and reduce costs. Allowing parties to claim an hourly rate for time spent preparing and appearing would undermine the legislative choice that each party normally bears its own extrajudicial costs, absent abuse of process. The judge emphasized that the time a party spends preparing its case, gathering evidence, and instituting proceedings is not recoverable as direct damage and is not compensable as a matter of course. Moreover, the particular hourly loss claimed belonged personally to Mr. Bruce Noivo, who was not himself a party to the litigation; the named party was the corporation Pharmacie Bruce Noivo et Aleksandar Vulic inc. For all these reasons, the counterclaim was dismissed in its entirety.

Ruling and overall outcome

In the result, the Court of Québec concluded that the interest clause, read together with the definition and adjustment of the “solde de prix de vente,” required that interest be calculated on the actual adjusted balance of 583,391.44$, not on the initial 1,000,000$ figure. Pharmacie Ian-Philip Paul-Hus inc.’s claim for additional interest beyond the 35,004.49$ already paid therefore failed and was dismissed. The counterclaim by Pharmacie Bruce Noivo et Aleksandar Vulic inc. for compensation for its time and related expenses was also dismissed as legally unfounded and unsupported. On costs, the court departed from the usual rule that the successful party recovers judicial costs, holding instead that each party would bear its own costs because both parties had failed to clarify the interpretation of clause 4.3.2 at the time of contracting. As both the principal claim and the counterclaim were rejected and no costs were awarded against the other, there was effectively no successful party and no monetary award, damages, or recoverable costs granted in favour of either side; the total quantified amount ordered in favour of any party was 0$, and no precise compensable amount can be identified beyond that.